title: VIGOR, an annotation program for small viral genomes.
abstract: BACKGROUND
  the decrease in cost for sequencing and improvement in technologies has made it easier and more common for the re-sequencing of large genomes as well as parallel sequencing of small genomes. It is possible to completely sequence a small genome within days and this increases the number of publicly available genomes. Among the types of genomes being rapidly sequenced are those of microbial and viral genomes responsible for infectious diseases. However, accurate gene prediction is a challenge that persists for decoding a newly sequenced genome. Therefore, accurate and efficient gene prediction programs are highly desired for rapid and cost effective surveillance of RNA viruses through full genome sequencing.
  
  
  RESULTS
  we have developed VIGOR (Viral Genome ORF Reader), a web application tool for gene prediction in influenza virus, rotavirus, rhinovirus and coronavirus subtypes. VIGOR detects protein coding regions based on sequence similarity searches and can accurately detect genome specific features such as frame shifts, overlapping genes, embedded genes, and can predict mature peptides within the context of a single polypeptide open reading frame. Genotyping capability for influenza and rotavirus is built into the program. We compared VIGOR to previously described gene prediction programs, ZCURVE_V, GeneMarkS and FLAN. The specificity and sensitivity of VIGOR are greater than 99% for the RNA viral genomes tested.
  
  
  CONCLUSIONS
  VIGOR is a user friendly web-based genome annotation program for five different viral agents, influenza, rotavirus, rhinovirus, coronavirus and SARS coronavirus. This is the first gene prediction program for rotavirus and rhinovirus for public access. VIGOR is able to accurately predict protein coding genes for the above five viral types and has the capability to assign function to the predicted open reading frames and genotype influenza virus. The prediction software was designed for performing high throughput annotation and closure validation in a post-sequencing production pipeline.
authors.affiliation: J, Craig Venter Institute, 9704 Medical Center Drive, Rockville, MD 20850, USA. shiliang@jcvi.org
authors.forename: Shiliang
authors.initials: S
authors.lastname: Wang
authors.forename: Jaideep P
authors.initials: JP
authors.lastname: Sundaram
authors.forename: David
authors.initials: D
authors.lastname: Spiro
mesh_terms: D018387:Codon, Initiator; D018388:Codon, Terminator; D019295:Computational Biology / Q000379:methods; D030541:Databases, Genetic; D016679:Genome, Viral / Q000235:genetics*; D058977:Molecular Sequence Annotation / Q000379:methods*; D016366:Open Reading Frames; D009975:Orthomyxoviridae / Q000235:genetics; D012984:Software
chemical_list: D018387:Codon, Initiator; D018388:Codon, Terminator
references.citation: J Virol. 2008 Apr;82(7):3204-19
references.pmid: 18216098
references.citation: Biochem Biophys Res Commun. 2003 Jul 25;307(2):382-8
references.pmid: 12859968
references.citation: Nat Med. 2001 Dec;7(12):1306-12
references.pmid: 11726970
references.citation: Curr Opin Microbiol. 2004 Aug;7(4):412-9
references.pmid: 15358261
references.citation: BMC Bioinformatics. 2004 Jun 06;5:72
references.pmid: 15180906
references.citation: Nat Rev Microbiol. 2005 Aug;3(8):591-600
references.pmid: 16064053
references.citation: Nucleic Acids Res. 2007 Jul;35(Web Server issue):W280-4
references.pmid: 17545199
references.citation: Biochem Soc Trans. 2004 Dec;32(Pt 6):1081-3
references.pmid: 15506971
references.citation: Nucleic Acids Res. 1982 Jan 22;10(2):459-72
references.pmid: 7063411
references.citation: J Virol. 2003 Apr;77(8):5026-9
references.pmid: 12663812
references.citation: Nucleic Acids Res. 2003 Dec 1;31(23):7041-55
references.pmid: 14627837
references.citation: Lancet. 2003 Nov 22;362(9397):1733-45
references.pmid: 14643124
references.citation: Science. 2005 Oct 28;310(5748):676-9
references.pmid: 16195424
references.citation: Virology. 2007 Jun 20;363(1):1-10
references.pmid: 17434558
references.citation: Novartis Found Symp. 2001;238:82-96; discussion 96-100
references.pmid: 11444037
references.citation: J Virol. 2008 Dec;82(24):12422-31
references.pmid: 18842722
references.citation: J Virol. 2007 Oct;81(19):10280-91
references.pmid: 17634238
references.citation: Annu Rev Genet. 2002;36:305-32
references.pmid: 12429695
references.citation: J Virol. 2006 Dec;80(23):11610-20
references.pmid: 16971428
references.citation: Vaccine. 2005 Dec 1;23(48-49):5666-9
references.pmid: 16269206
references.citation: Nucleic Acids Res. 1994 Nov 11;22(22):4756-67
references.pmid: 7984428
references.citation: Virology. 2007 Feb 20;358(2):424-35
references.pmid: 17023013
references.citation: Bioinformatics. 2004 May 1;20(7):1074-80
references.pmid: 14764577
references.citation: Nucleic Acids Res. 1999 Oct 1;27(19):3911-20
references.pmid: 10481031
references.citation: PLoS Pathog. 2009 Oct;5(10):e1000634
references.pmid: 19851457
references.citation: J Virol. 2007 May;81(10):4981-90
references.pmid: 17344285
references.citation: BMC Bioinformatics. 2006 Jan 10;7:9
references.pmid: 16401352
references.citation: Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
references.pmid: 9254694
references.citation: Virol J. 2007 May 03;4:40
references.pmid: 17477878
references.citation: Science. 2009 Apr 3;324(5923):55-9
references.pmid: 19213880